Animal models of ulcerative colitis and their application in drug research

References

• Molodecky NA Soon IS Rabi DM Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review Gastroenterology 2012 142 1 46 54 e42 quiz e30 22001864
   PubMed Web of Science ®Google Scholar
• Loftus EVJr Sandborn WJ Epidemiology of inflammatory bowel disease Gastroenterol Clin North Am 2002 31 1 1 20 12122726
   PubMed Web of Science ®Google Scholar
• Park KT Bass D Inflammatory bowel disease-attributable costs and cost-effective strategies in the United States: a review Inflamm Bowel Dis 2011 17 7 1603 1609 21053357
   PubMed Web of Science ®Google Scholar
• Akolkar PN Gulwani-Akolkar B Heresbach D Differences in risk of Crohn’s disease in offspring of mothers and fathers with inflammatory bowel disease Am J Gastroenterol 1997 92 12 2241 2244 9399762
   PubMed Web of Science ®Google Scholar
• Fransen K Mitrovic M van Diemen CC Limited evidence for parent-of-origin effects in inflammatory bowel disease associated loci PLoS One 2012 7 9 e45287 23028907
   PubMed Web of Science ®Google Scholar
• Anderson CA Boucher G Lees CW Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47 Nat Genet 2011 43 3 246 252 21297633
   PubMed Web of Science ®Google Scholar
• Lewis JD Aberra FN Lichtenstein GR Bilker WB Brensinger C Strom BL Seasonal variation in fares of inflammatory bowel disease Gastroenterology 2004 126 3 665 673 14988820
   PubMed Web of Science ®Google Scholar
• Mahid SS Minor KS Soto RE Hornung CA Galandiuk S Smoking and inflammatory bowel disease: a meta-analysis Mayo Clin Proc 2006 81 11 1462 1471 17120402
   PubMed Web of Science ®Google Scholar
• Bergeron V Grondin V Rajca S Current smoking differentially affects blood mononuclear cells from patients with Crohn’s disease and ulcerative colitis: relevance to its adverse role in the disease Inflamm Bowel Dis 2012 18 6 1101 1111 21987436
   PubMed Web of Science ®Google Scholar
• Denson LA Long MD McGovern DP Challenges in IBD research: update on progress and prioritization of the CCFA’s research agenda Inflamm Bowel Dis 2013 19 4 677 682 23448796
   PubMed Web of Science ®Google Scholar
• Kawada M Arihiro A Mizoguchi E Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease World J Gastroenterol 2007 13 42 5581 5593 17948932
   PubMed Web of Science ®Google Scholar
• Mizoguchi A Animal models of inflammatory bowel disease Conn PM Progress in Molecular Biology and Translational Science 105 San Diego, CA Academic Press 2012
   Google Scholar
• Boirivant M Fuss IJ Chu A Strober W Oxazolone colitis: a murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4 J Exp Med 1998 188 10 1929 1939 9815270
   PubMed Web of Science ®Google Scholar
• Heller F Fuss IJ Nieuwenhuis EE Blumberg RS Strober W Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells Immunity 2002 17 5 629 638 12433369
   PubMed Web of Science ®Google Scholar
• Ikeda M Takeshima F Isomoto H Simvastatin attenuates trinitrobenzene sulfonic acid-induced colitis, but not oxazalone-induced colitis Dig Dis Sci 2008 53 7 1869 1875 18049901
   PubMed Web of Science ®Google Scholar
• Galitovskiy V Qian J Chernyavsky AI Cytokine-induced alterations of alpha7 nicotinic receptor in colonic CD4 T cells mediate dichotomous response to nicotine in murine models of Th1/Th17- versus Th2-mediated colitis J Immunol 2011 187 5 2677 2687 21784975
   PubMed Web of Science ®Google Scholar
• MacPherson BR Pfeiffer CJ Experimental production of diffuse colitis in rats Digestion 1978 17 2 135 150 627326
   PubMed Web of Science ®Google Scholar
• Elson CO Sartor RB Tennyson GS Riddell RH Experimental models of inflammatory bowel disease Gastroenterology 1995 109 4 1344 1367 7557106
   PubMed Web of Science ®Google Scholar
• Cetinkaya A Bulbuloglu E Kurutas EB Ciralik H Kantarceken B Buyukbese MA Beneficial effects of N-acetylcysteine on acetic acid-induced colitis in rats Tohoku J Exp Med 2005 206 2 131 139 15888969
   PubMed Web of Science ®Google Scholar
• Kuralay F Yildiz C Ozutemiz O Effects of trimetazidine on acetic acid-induced colitis in female Swiss rats J Toxicol Environ Health A 2003 66 2 169 179 12653021
   PubMed Web of Science ®Google Scholar
• Yoshida N Yoshikawa T Yamaguchi T A novel water-soluble vitamin E derivative protects against experimental colitis in rats Antioxid Redox Signal 1999 1 4 555 562 11233152
   PubMed Web of Science ®Google Scholar
• Tahan G Gramignoli R Marongiu F Melatonin expresses powerful anti-inflammatory and antioxidant activities resulting in complete improvement of acetic-acid-induced colitis in rats Dig Dis Sci 2011 56 3 715 720 20676767
   PubMed Web of Science ®Google Scholar
• Mann BJ Burkholder BV Lockhart LA Protection in a gerbil model of amebiasis by oral immunization with Salmonella expressing the galactose/N-acetyl D-galactosamine inhibitable lectin of Entamoeba histolytica Vaccine 1997 15 6–7 659 663 9178467
   PubMed Web of Science ®Google Scholar
• Mizoguchi E Chitinase 3-like-1 exacerbates intestinal inflammation by enhancing bacterial adhesion and invasion in colonic epithelial cells Gastroenterology 2006 130 2 398 411 16472595
   PubMed Web of Science ®Google Scholar
• Boudeau J Glasser AL Masseret E Joly B Darfeuille-Michaud A Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn’s disease Infect Immun 1999 67 9 4499 4509 10456892
   PubMed Web of Science ®Google Scholar
• Jensen SR Fink LN Nielsen OH Brynskov J Brix S Ex vivo intestinal adhesion of Escherichia coli LF82 in Crohn’s disease Microb Pathog 2011 51 6 426 431 21911052
   PubMed Web of Science ®Google Scholar
• Low D Tran HT Lee IA Chitin-binding domains of Escherichia coli chiA mediate interactions with intestinal epithelial cells in mice with colitis Gastroenterology 2013 145 3 602 612 23684751
   PubMed Web of Science ®Google Scholar
• Nagatani K Wang S Llado V Chitin microparticles for the control of intestinal inflammation Inflamm Bowel Dis 2012 18 9 1698 1710 22241684
   PubMed Web of Science ®Google Scholar
• Ingrassia I Leplingard A Darfeuille-Michaud A Lactobacillus casei DN-114 001 inhibits the ability of adherent-invasive Escherichia coli isolated from Crohn’s disease patients to adhere to and to invade intestinal epithelial cells Appl Environ Microbiol 2005 71 6 2880 2887 15932981
   PubMed Web of Science ®Google Scholar
• Drouet M Vignal C Singer E AIEC colonization and pathogenicity: influence of previous antibiotic treatment and preexisting inflammation Inflamm Bowel Dis 2012 18 10 1923 1931 22344932
   PubMed Web of Science ®Google Scholar
• Watanabe M Ueno Y Yajima T Interleukin 7 is produced by human intestinal epithelial cells and regulates the proliferation of intestinal mucosal lymphocytes J Clin Invest 1995 95 6 2945 2953 7769137
   PubMed Web of Science ®Google Scholar
• Watanabe M Watanabe N Iwao Y The serum factor from patients with ulcerative colitis that induces T cell proliferation in the mouse thymus is interleukin-7 J Clin Immunol 1997 17 4 282 292 9258767
   PubMed Web of Science ®Google Scholar
• Shinohara T Nemoto Y Kanai T Upregulated IL-7 receptor alpha expression on colitogenic memory CD4+ T cells may participate in the development and persistence of chronic colitis J Immunol 2011 186 4 2623 2632 21217010
   PubMed Web of Science ®Google Scholar
• Yamazaki M Yajima T Tanabe M Mucosal T cells expressing high levels of IL-7 receptor are potential targets for treatment of chronic colitis J Immunol 2003 171 3 1556 1563 12874249
   PubMed Web of Science ®Google Scholar
• Willis CR Seamons A Maxwell J Interleukin-7 receptor blockade suppresses adaptive and innate inflammatory responses in experimental colitis J Inflamm (Lond) 2012 9 1 39 23057802
   PubMed Web of Science ®Google Scholar
• Watanabe M Ueno Y Yajima T Interleukin 7 transgenic mice develop chronic colitis with decreased interleukin 7 protein accumulation in the colonic mucosa J Exp Med 1998 187 3 389 402 9449719
   PubMed Web of Science ®Google Scholar
• Mombaerts P Mizoguchi E Grusby MJ Glimcher LH Bhan AK Tonegawa S Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice Cell 1993 75 2 274 282 8104709
   PubMed Web of Science ®Google Scholar
• Dianda L Hanby AM Wright NA Sebesteny A Hayday AC Owen MJ T cell receptor-alpha beta-deficient mice fail to develop colitis in the absence of a microbial environment Am J Pathol 1997 150 1 91 97 9006326
   PubMed Web of Science ®Google Scholar
• Shimomura Y Mizoguchi E Sugimoto K Regulatory role of B-1 B cells in chronic colitis Int Immunol 2008 20 6 729 737 18375938
   PubMed Web of Science ®Google Scholar
• Nishiyori A Nagakura Y Ichikawa K Piroxicam accelerates development of colitis in T-cell receptor alpha chain-deficient mice Eur J Pharmacol 2009 615 1–3 241 245 19446544
   PubMed Web of Science ®Google Scholar
• Iijima H Takahashi I Kishi D Alteration of interleukin 4 production results in the inhibition of T helper type 2 cell-dominated inflammatory bowel disease in T cell receptor alpha chain-deficient mice J Exp Med 1999 190 5 607 615 10477546
   PubMed Web of Science ®Google Scholar
• Mizoguchi A Mizoguchi E Smith RN Preffer FI Bhan AK Suppressive role of B cells in chronic colitis of T cell receptor alpha mutant mice J Exp Med 1997 186 10 1749 1756 9362534
   PubMed Web of Science ®Google Scholar
• Sheikh SZ Hegazi RA Kobayashi T An anti-inflammatory role for carbon monoxide and heme oxygenase-1 in chronic Th2-mediated murine colitis J Immunol 2011 186 9 5506 5513 21444764
   PubMed Web of Science ®Google Scholar
• Hsieh KH Chang MH Lee CY Wang CY Wiskott-Aldrich syndrome and inflammatory bowel disease Ann Allergy 1988 60 5 429 431 3369753
   PubMedGoogle Scholar
• Dupuis-Girod S Medioni J Haddad E Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients Pediatrics 2003 111 5 Pt 1 e622 e627 12728121
   PubMed Web of Science ®Google Scholar
• Snapper SB Rosen FS Mizoguchi E Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation Immunity 1998 9 1 81 91 9697838
   PubMed Web of Science ®Google Scholar
• Nguyen DD Maillard MH Cotta-de-Almeida V Lymphocyte-dependent and Th2 cytokine-associated colitis in mice deficient in Wiskott-Aldrich syndrome protein Gastroenterology 2007 133 4 1188 1197 17764675
   PubMed Web of Science ®Google Scholar
• Nguyen DD Wurbel MA Goettel JA Wiskott-Aldrich syndrome protein deficiency in innate immune cells leads to mucosal immune dysregulation and colitis in mice Gastroenterology 2012 143 3 719 729 22710191
   PubMed Web of Science ®Google Scholar
• Klein C Nguyen D Liu CH Gene therapy for Wiskott-Aldrich syndrome: rescue of T-cell signaling and amelioration of colitis upon transplantation of retrovirally transduced hematopoietic stem cells in mice Blood 2003 101 6 2159 2166 12433691
   PubMed Web of Science ®Google Scholar
• Tuin A Poelstra K de Jager-Krikken A Role of alkaline phosphatase in colitis in man and rats Gut 2009 58 3 379 387 18852260
   PubMed Web of Science ®Google Scholar
• Ramasamy S Nguyen DD Eston MA Intestinal alkaline phosphatase has beneficial effects in mouse models of chronic colitis Inflamm Bowel Dis 2011 17 2 532 542 20645323
   PubMed Web of Science ®Google Scholar
• Panwala CM Jones JC Viney JL A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis J Immunol 1998 161 10 5733 5744 9820555
   PubMed Web of Science ®Google Scholar
• Tanner SM Staley EM Lorenz RG Altered generation of induced regulatory T cells in the FVB.mdr1a−/− mouse model of colitis Mucosal Immunol 2013 6 2 309 323 22874899
   PubMed Web of Science ®Google Scholar
• Staley EM Dimmitt RA Schoeb TR Tanner SM Lorenz RG Critical role for P-glycoprotein expression in hematopoietic cells in the FVB. Mdr1a(−/−) model of colitis J Pediatr Gastroenterol Nutr 2011 53 6 666 673 21681110
   PubMed Web of Science ®Google Scholar
• Nones K Dommels YE Martell S The effects of dietary curcumin and rutin on colonic inflammation and gene expression in multidrug resistance gene-deficient (mdr1a−/−) mice, a model of inflammatory bowel diseases Br J Nutr 2009 101 2 169 181 18761777
   PubMed Web of Science ®Google Scholar
• Annese V Valvano MR Palmieri O Latiano A Bossa F Andriulli A Multidrug resistance 1 gene in inflammatory bowel disease: a meta-analysis World J Gastroenterol 2006 12 23 3636 3644 16773678
   PubMed Web of Science ®Google Scholar
• Langmann T Moehle C Mauerer R Loss of detoxification in inflammatory bowel disease: dysregulation of pregnane X receptor target genes Gastroenterology 2004 127 1 26 40 15236169
   PubMed Web of Science ®Google Scholar
• Saksena S Goyal S Raheja G Upregulation of P-glycoprotein by probiotics in intestinal epithelial cells and in the dextran sulfate sodium model of colitis in mice Am J Physiol Gastrointest Liver Physiol 2011 300 6 G1115 G1123 21350189
   PubMed Web of Science ®Google Scholar
• Sadlack B Merz H Schorle H Schimpl A Feller AC Horak I Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene Cell 1993 75 2 253 261 8402910
   PubMed Web of Science ®Google Scholar
• Cruickshank SM English NR Felsburg PJ Carding SR Characterization of colonic dendritic cells in normal and colitic mice World J Gastroenterol 2005 11 40 6338 6347 16419163
   PubMed Web of Science ®Google Scholar
• Waidmann M Bechtold O Frick JS Bacteroides vulgatus protects against Escherichia coli-induced colitis in gnotobiotic interleukin-2-deficient mice Gastroenterology 2003 125 1 162 177 12851881
   PubMed Web of Science ®Google Scholar
• Muller M Fink K Geisel J Intestinal colonization of IL-2 deficient mice with non-colitogenic B. vulgatus prevents DC maturation and T-cell polarization PLoS One 2008 3 6 e2376 18545662
   PubMed Web of Science ®Google Scholar
• Contractor NV Bassiri H Reya T Lymphoid hyperplasia, autoimmunity, and compromised intestinal intraepithelial lymphocyte development in colitis-free gnotobiotic IL-2-deficient mice J Immunol 1998 160 1 385 394 9551995
   PubMed Web of Science ®Google Scholar
• Ludviksson BR Strober W Nishikomori R Hasan SK Ehrhardt RO Administration of mAb against alpha E beta 7 prevents and ameliorates immunization-induced colitis in IL-2−/− mice J Immunol 1999 162 8 4975 4982 10202045
   PubMed Web of Science ®Google Scholar
• Varilek GW Yang F Lee EY Green tea polyphenol extract attenuates inflammation in interleukin-2-deficient mice, a model of autoimmunity J Nutr 2001 131 7 2034 2039 11435526
   PubMed Web of Science ®Google Scholar
• Rudolph U Finegold MJ Rich SS Ulcerative colitis and adenocarcinoma of the colon in G alpha i2-deficient mice Nat Genet 1995 10 2 143 150 7663509
   PubMed Web of Science ®Google Scholar
• Hornquist CE Lu X Rogers-Fani PM G(alpha)i2-deficient mice with colitis exhibit a local increase in memory CD4+ T cells and proinflammatory Th1-type cytokines J Immunol 1997 158 3 1068 1077 9013944
   PubMed Web of Science ®Google Scholar
• Bjursten M Willen R Hultgren Hornquist E Transfer of colitis by Galphai2-deficient T lymphocytes: impact of subpopulations and tissue origin Inflamm Bowel Dis 2005 11 11 997 1005 16239846
   PubMed Web of Science ®Google Scholar
• Dalwadi H Wei B Schrage M B cell developmental requirement for the G alpha i2 gene J Immunol 2003 170 4 1707 1715 12574334
   PubMed Web of Science ®Google Scholar
• Ohman L Willen R Hultgren OH Hultgren Hornquist E Acellular Bordetella pertussis vaccine enhances mucosal interleukin-10 production, induces apoptosis of activated Th1 cells and attenuates colitis in Galphai2-deficient mice Clin Exp Immunol 2005 141 1 37 46 15958068
   PubMed Web of Science ®Google Scholar
• Fritsch Fredin M Vidal A Utkovic H The application and relevance of ex vivo culture systems for assessment of IBD treatment in murine models of colitis Pharmacol Res 2008 58 3–4 222 231 18812224
   PubMed Web of Science ®Google Scholar
• Lin J Hackam DJ Worms, flies and four-legged friends: the applicability of biological models to the understanding of intestinal inflammatory diseases Dis Model Mech 2011 4 4 447 456 21669933
   PubMed Web of Science ®Google Scholar
• Briskin M Winsor-Hines D Shyjan A Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue Am J Pathol 1997 151 1 97 110 9212736
   PubMed Web of Science ®Google Scholar
• Podolsky DK Lobb R King N Attenuation of colitis in the cotton-top tamarin by anti-alpha 4 integrin monoclonal antibody J Clin Invest 1993 92 1 372 380 7686922
   PubMed Web of Science ®Google Scholar
• Hesterberg PE Winsor-Hines D Briskin MJ Rapid resolution of chronic colitis in the cotton-top tamarin with an antibody to a gut-homing integrin alpha 4 beta 7 Gastroenterology 1996 111 5 1373 1380 8898653
   PubMed Web of Science ®Google Scholar
• Picarella D Hurlbut P Rottman J Shi X Butcher E Ringler DJ Monoclonal antibodies specific for beta 7 integrin and mucosal addressin cell adhesion molecule-1 (MAdCAM-1) reduce inflammation in the colon of scid mice reconstituted with CD45RBhigh CD4+ T cells J Immunol 1997 158 5 2099 2106 9036954
   PubMed Web of Science ®Google Scholar
• Neurath MF New targets for mucosal healing and therapy in inflammatory bowel diseases Mucosal Immunol 2013
   Web of Science ®Google Scholar
• Sandborn WJ Colombel JF Enns R Natalizumab induction and maintenance therapy for Crohn’s disease N Engl J Med 2005 353 18 1912 1925 16267322
   PubMed Web of Science ®Google Scholar
• Targan SR Feagan BG Fedorak RN Natalizumab for the treatment of active Crohn’s disease: results of the ENCORE trial Gastroenterology 2007 132 5 1672 1683 17484865
   PubMed Web of Science ®Google Scholar
• Feagan BG Rutgeerts P Sands BE Vedolizumab as induction and maintenance therapy for ulcerative colitis N Engl J Med 2013 369 8 699 710 23964932
   PubMed Web of Science ®Google Scholar
• Rutgeerts PJ Fedorak RN Hommes DW A randomised phase I study of etrolizumab (rhuMAb beta7) in moderate to severe ulcerative colitis Gut 2013 62 8 1122 1130 22717454
   PubMed Web of Science ®Google Scholar
• Vermeire S Ghosh S Panes J The mucosal addressin cell adhesion molecule antibody PF-00547,659 in ulcerative colitis: a randomised study Gut 2011 60 8 1068 1075 21317177
   PubMed Web of Science ®Google Scholar
• Yacyshyn BR Bowen-Yacyshyn MB Jewell L A placebo-controlled trial of ICAM-1 antisense oligonucleotide in the treatment of Crohn’s disease Gastroenterology 1998 114 6 1133 1142 9609749
   PubMed Web of Science ®Google Scholar
• Yacyshyn BR Chey WY Goff J Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn’s disease Gut 2002 51 1 30 36 12077088
   PubMed Web of Science ®Google Scholar
• Miner PBJr Wedel MK Xia S Baker BF Safety and efficacy of two dose formulations of alicaforsen enema compared with mesalazine enema for treatment of mild to moderate left-sided ulcerative colitis: a randomized, double-blind, active-controlled trial Aliment Pharmacol Ther 2006 23 10 1403 1413 16669955
   PubMed Web of Science ®Google Scholar
• Coskun M Salem M Pedersen J Nielsen OH Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease Pharmacol Res 2013 76C 1 8 23827161
   PubMed Web of Science ®Google Scholar
• Durant L Watford WT Ramos HL Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis Immunity 2010 32 5 605 615 20493732
   PubMed Web of Science ®Google Scholar
• Uckun FM Tibbles H Ozer Z Qazi S Vassilev A Anti-inflammatory activity profile of JANEX-1 in preclinical animal models Bioorg Med Chem 2008 16 3 1287 1298 18024136
   PubMed Web of Science ®Google Scholar
• Sandborn WJ Ghosh S Panes J Tofacitinib, an oral Janus kinase inhibitor, in active ulcerative colitis N Engl J Med 2012 367 7 616 624 22894574
   PubMed Web of Science ®Google Scholar
• Gilat T Hacohen D Lilos P Langman MJ Childhood factors in ulcerative colitis and Crohn’s disease. An international cooperative study Scand J Gastroenterol 1987 22 8 1009 1024 3685876
   PubMed Web of Science ®Google Scholar
• Andersson RE Olaison G Tysk C Ekbom A Appendectomy and protection against ulcerative colitis N Engl J Med 2001 344 11 808 814 11248156
   PubMed Web of Science ®Google Scholar
• Mizoguchi A Mizoguchi E Chiba C Bhan AK Role of appendix in the development of inflammatory bowel disease in TCR-alpha mutant mice J Exp Med 1996 184 2 707 715 8760824
   PubMed Web of Science ®Google Scholar
• Krieglstein CF Cerwinka WH Laroux FS Role of appendix and spleen in experimental colitis J Surg Res 2001 101 2 166 175 11735272
   PubMed Web of Science ®Google Scholar
• Farkas SA Hornung M Sattler C Preferential migration of CD62L cells into the appendix in mice with experimental chronic colitis Eur Surg Res 2005 37 2 115 122 15905618
   PubMed Web of Science ®Google Scholar
• Blum AM Hang L Setiawan T Heligmosomoides polygyrus bakeri induces tolerogenic dendritic cells that block colitis and prevent antigen-specific gut T cell responses J Immunol 2012 189 5 2512 2520 22844110
   PubMed Web of Science ®Google Scholar
• Leung JM Loke P A role for IL-22 in the relationship between intestinal helminths, gut microbiota and mucosal immunity Int J Parasitol 2013 43 3–4 253 257 23178750
   PubMed Web of Science ®Google Scholar
• Ferreira I Smyth D Gaze S Hookworm excretory/secretory products induce interleukin-4 (IL-4)+ IL-10+ CD4+ T cell responses and suppress pathology in a mouse model of colitis Infect Immun 2013 81 6 2104 2111 23545299
   PubMed Web of Science ®Google Scholar
• Cantacessi C Young ND Nejsum P The transcriptome of Trichuris suis: first molecular insights into a parasite with curative properties for key immune diseases of humans PLoS One 2011 6 8 e23590 21887281
   PubMed Web of Science ®Google Scholar
• Du L Tang H Ma Z The protective effect of the recombinant 53-kDa protein of Trichinella spiralis on experimental colitis in mice Dig Dis Sci 2011 56 10 2810 2817 21476030
   PubMed Web of Science ®Google Scholar
• Bager P Vinkel Hansen A Wohlfahrt J Melbye M Helminth infection does not reduce risk for chronic inflammatory disease in a population-based cohort study Gastroenterology 2012 142 1 55 62 21983081
   PubMed Web of Science ®Google Scholar
• Wang A Fernando M Leung G Phan V Smyth D McKay DM Exacerbation of oxazolone colitis by infection with the helminth Hymenolepis diminuta: involvement of IL-5 and eosinophils Am J Pathol 2010 177 6 2850 2859 21037078
   PubMed Web of Science ®Google Scholar
• Wang LJ Cao Y Shi HN Helminth infections and intestinal inflammation World J Gastroenterol 2008 14 33 5125 5132 18777588
   PubMed Web of Science ®Google Scholar
• Duijvestein M Vos AC Roelofs H Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn’s disease: results of a phase I study Gut 2010 59 12 1662 1669 20921206
   PubMed Web of Science ®Google Scholar
• Srivastava AS Feng Z Mishra R Malhotra R Kim HS Carrier E Embryonic stem cells ameliorate piroxicam-induced colitis in IL10−/− KO mice Biochem Biophys Res Commun 2007 361 4 953 959 17692287
   PubMed Web of Science ®Google Scholar
• Zhou Q Price DD Dreher KL Localized colonic stem cell transplantation enhances tissue regeneration in murine colitis J Cell Mol Med 2012 16 8 1900 1915 22050903
   PubMed Web of Science ®Google Scholar
• Hayashi Y Tsuji S Tsujii M The transdifferentiation of bone-marrow-derived cells in colonic mucosal regeneration after dextran-sulfate-sodium-induced colitis in mice Pharmacology 2007 80 4 193 199 17587885
   PubMed Web of Science ®Google Scholar
• Godoi DF Cardoso CR Silva MJ Reappraisal of total body irradiation followed by bone marrow transplantation as a therapy for inflammatory bowel disease Immunobiology 2013 218 3 317 324 22771114
   PubMed Web of Science ®Google Scholar
• He XW He XS Lian L Wu XJ Lan P Systemic infusion of bone marrow-derived mesenchymal stem cells for treatment of experimental colitis in mice Dig Dis Sci 2012 57 12 3136 3144 22752635
   PubMed Web of Science ®Google Scholar
• Akiyama K Chen C Wang D Mesenchymal-stem-cell-induced immunoregulation involves Fas-ligand-/Fas-mediated T cell apoptosis Cell Stem Cell 2012 10 5 544 555 22542159
   PubMed Web of Science ®Google Scholar
• Tanaka F Tominaga K Ochi M Exogenous administration of mesenchymal stem cells ameliorates dextran sulfate sodium-induced colitis via anti-inflammatory action in damaged tissue in rats Life Sci 2008 83 23–24 771 779 18950645
   PubMed Web of Science ®Google Scholar
• Hayashi Y Tsuji S Tsujii M Topical implantation of mesenchymal stem cells has beneficial effects on healing of experimental colitis in rats J Pharmacol Exp Ther 2008 326 2 523 531 18448866
   PubMed Web of Science ®Google Scholar
• Claes IJ De Keersmaecker SC Vanderleyden J Lebeer S Lessons from probiotic-host interaction studies in murine models of experimental colitis Mol Nutr Food Res 2011 55 10 1441 1453 21796777
   PubMed Web of Science ®Google Scholar
• Bennet JD Brinkman M Treatment of ulcerative colitis by implantation of normal colonic flora Lancet 1989 1 8630 164 2563083
   PubMed Web of Science ®Google Scholar
• Couturier-Maillard A Secher T Rehman A NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer J Clin Invest 2013 123 2 700 711 23281400
   PubMed Web of Science ®Google Scholar
• Kahn SA Vachon A Rodriquez D Patient perceptions of fecal microbiota transplantation for ulcerative colitis Inflamm Bowel Dis 2013 19 7 1506 1513 23624888
   PubMed Web of Science ®Google Scholar
• Ng SC Lam YT Tsoi KK Chan FK Sung JJ Wu JC Systematic review: the efficacy of herbal therapy in inflammatory bowel disease Aliment Pharmacol Ther 2013 38 8 854 863 23981095
   PubMed Web of Science ®Google Scholar
• Ke F Yadav PK Ju LZ Herbal medicine in the treatment of ulcerative colitis Saudi J Gastroenterol 2012 18 1 3 10 22249085
   PubMed Web of Science ®Google Scholar
• Langmead L Feakins RM Goldthorpe S Randomized, doubleblind, placebo-controlled trial of oral aloe vera gel for active ulcerative colitis Aliment Pharmacol Ther 2004 19 7 739 747 15043514
   PubMed Web of Science ®Google Scholar
• Ben-Arye E Goldin E Wengrower D Stamper A Kohn R Berry E Wheat grass juice in the treatment of active distal ulcerative colitis: a randomized double-blind placebo-controlled trial Scand J Gastroenterol 2002 37 4 444 449 11989836
   PubMed Web of Science ®Google Scholar
• Tang T Targan SR Li ZS Xu C Byers VS Sandborn WJ Randomised clinical trial: herbal extract HMPL-004 in active ulcerative colitis – a double-blind comparison with sustained release mesalazine Aliment Pharmacol Ther 2011 33 2 194 202 21114791
   PubMed Web of Science ®Google Scholar
• Langhorst J Varnhagen I Schneider SB Randomised clinical trial: a herbal preparation of myrrh, chamomile and coffee charcoal compared with mesalazine in maintaining remission in ulcerative colitis: a double-blind, double-dummy study Aliment Pharmacol Ther 2013 38 5 490 500 23826890
   PubMed Web of Science ®Google Scholar
• Hanai H Iida T Takeuchi K Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial Clin Gastroenterol Hepatol 2006 4 12 1502 1506 17101300
   PubMed Web of Science ®Google Scholar
• Michelsen KS Wong MH Ko B Thomas LS Dhall D Targan SR HMPL-004 (Andrographis paniculata extract) prevents development of murine colitis by inhibiting T-cell proliferation and TH1/TH17 responses Inflamm Bowel Dis 2013 19 1 151 164 23292349
   PubMed Web of Science ®Google Scholar